[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Medical News & Perspectives
July 9, 2008

Studies Explore Factors That Underlie Varied Responses to Cancer Drugs

JAMA. 2008;300(2):155-156. doi:10.1001/jama.300.2.155

Chicago—New research findings in the field of personalized medicine could help oncologists understand the characteristics that determine why patients respond differently to therapeutic drugs. The studies were presented recently at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).

“This exciting field gives cancer doctors new tools to identify the most appropriate treatment for each patient while avoiding overtreatment with drugs that have potentially toxic side effects,” said Julie Gralow, MD, chair of ASCO's cancer communications committee and associate professor of medicine at the University of Washington in Seattle.

First Page Preview View Large
First page PDF preview
First page PDF preview
×